Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel

BACKGROUND: Peripheral neuropathy is a common dose-limiting side effect of paclitaxel. To date, there is no effective strategy to prevent paclitaxel-induced peripheral neuropathy. A recent small phase II study demonstrated the potential role of oral gabapentin in this setting. This phase III study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Praful, Kumar, Akash, Pushpam, Deepam, Khurana, Sachin, Malik, Prabhat Singh, Gogia, Ajay, Arunmozhimaran, Elavarasi, Singh, Mamta Bhushan, Chandran, Dinu Santha, Batra, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896696/
https://www.ncbi.nlm.nih.gov/pubmed/36732774
http://dx.doi.org/10.1186/s13063-023-07126-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896696/
https://www.ncbi.nlm.nih.gov/pubmed/36732774
http://dx.doi.org/10.1186/s13063-023-07126-1

Ejemplares similares